Straumann Holding AG Total Current Liabilities 2012-2024 | SAUHY

Straumann Holding AG total current liabilities from 2012 to 2024. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
  • Straumann Holding AG total current liabilities for the quarter ending December 31, 2024 were $1.071B, a 111.25% increase year-over-year.
  • Straumann Holding AG total current liabilities for 2024 were $1.071B, a 34.67% increase from 2023.
  • Straumann Holding AG total current liabilities for 2023 were $0.796B, a 21.91% decline from 2022.
  • Straumann Holding AG total current liabilities for 2022 were $1.019B, a 65.48% increase from 2021.
Straumann Holding AG Annual Total Current Liabilities
(Millions of US $)
2024 $1,071
2023 $796
2022 $1,019
2021 $616
2020 $405
2019 $583
2018 $278
2017 $217
2016 $171
2015 $166
2014 $150
2013 $128
2012 $114
2011 $126
Straumann Holding AG Quarterly Total Current Liabilities
(Millions of US $)
2024-12-31 $1,071
2023-12-31 $796
2022-12-31 $1,019
2021-12-31 $616
2021-06-30 $507
2020-12-31 $405
2020-06-30 $448
2019-12-31 $583
2018-12-31 $278
2017-12-31 $217
2017-06-30 $172
2016-12-31 $171
2016-06-30 $169
2015-12-31 $166
2014-12-31 $150
2013-12-31 $128
2013-06-30 $112
2012-12-31 $114
2012-06-30 $146
2011-12-31 $126
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $20.753B $2.845B
The Straumann Group is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately on thousand seven hundred ninety people worldwide and its products and services are available in more than sixty countries through its broad network of distribution subsidiaries and partners.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $88.910B 21.47
Becton Dickinson (BDX) United States $49.385B 12.23
Cardinal Health (CAH) United States $36.396B 19.06
Labcorp (LH) United States $20.246B 16.42
Cooper (COO) United States $15.859B 21.03
West Pharmaceutical Services (WST) United States $14.979B 31.40
Align Technology (ALGN) United States $12.512B 24.84
Henry Schein (HSIC) United States $8.682B 14.89
Merit Medical Systems (MMSI) United States $5.621B 27.17
DENTSPLY SIRONA (XRAY) United States $3.159B 9.43
CONMED (CNMD) United States $1.734B 12.98
STAAR Surgical (STAA) United States $0.930B 0.00
Lifevantage (LFVN) United States $0.166B 17.14
Pro-Dex (PDEX) United States $0.149B 16.29